Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / CL A
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
5,378,939
-
Shares change
-
+5,378,939
-
Total reported value, excl. options
-
$106,232,525
-
Value change
-
+$106,232,525
-
Number of buys
-
41
-
Price
-
$19.75
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2016
41 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q2 2016.
REATA PHARMACEUTICALS INC - CL A (RETA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,378,939 shares
.
Largest 10 shareholders include Novo A/S (3,367,763 shares), FMR LLC (550,000 shares), JPMORGAN CHASE & CO (242,978 shares), EMERALD MUTUAL FUND ADVISERS TRUST (182,390 shares), EMERALD ADVISERS INC/PA (167,610 shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (150,000 shares), BlackRock Fund Advisors (147,097 shares), STATE STREET CORP (63,411 shares), GOLDMAN SACHS GROUP INC (55,104 shares), and BlackRock Institutional Trust Company, N.A. (53,629 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.